| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |